propylthiouracil and Hepatitis-C--Chronic

propylthiouracil has been researched along with Hepatitis-C--Chronic* in 1 studies

Other Studies

1 other study(ies) available for propylthiouracil and Hepatitis-C--Chronic

ArticleYear
Agranulocytosis during treatment of chronic hepatitis C complicated by hyperthyreosis. Case reports.
    Endokrynologia Polska, 2012, Volume: 63, Issue:1

    Agranulocytosis is a life-threatening disorder characterised by a greatly decreased number of circulating neutrophils below 500/μL. This article presents two cases of agranulocytosis in patients treated with pegylated interferon and ribavirin due to chronic hepatitis C. Interferon induced hyperthyroidism, which required the use of a tyreostatic. Anti-thyroid drugs (ATD) used to treat hyperthyroidism can cause agranulocytosis. The synergistic reaction of ATD and interferon on bone marrow cannot be excluded.

    Topics: Adult; Agranulocytosis; Antithyroid Agents; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hyperthyroidism; Interferon alpha-2; Interferon-alpha; Methimazole; Middle Aged; Polyethylene Glycols; Propylthiouracil; Recombinant Proteins; Ribavirin; Time Factors; Viral Load

2012